ArticleBlood advances2025

Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.

Ricarda Knabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.